- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: rHuPH20
Total 84 results
-
argenxCompletedHealthy VolunteersNetherlands
-
Thomas Jefferson UniversityJanssen Scientific Affairs, LLCActive, not recruitingPlasma Cell MyelomaUnited States
-
argenxCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedLymphedema | Malignant NeoplasmUnited States
-
PfizerHalozyme TherapeuticsTerminatedHealthy | HypercholesterolemiaBelgium
-
UMC UtrechtUnknown
-
Halozyme TherapeuticsCompletedDermatitis, Allergic ContactUnited States
-
Alexion PharmaceuticalsCompletedHealthyUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...Completed
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.CompletedChronic Inflammatory Demyelinating PolyradiculoneuropathySpain, Canada, Poland, Italy, Serbia, Germany, Mexico, Turkey, United Kingdom, Czechia, France, United States, Argentina, Brazil, Colombia, Denmark, Greece, Slovakia
-
Janssen Research & Development, LLCCompleted
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis (MS)United States
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
Bristol-Myers SquibbRecruitingMelanomaSpain, United States, Italy, Chile, Greece, Argentina
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)United States
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)United States
-
Baxter Healthcare CorporationHalozyme TherapeuticsCompleted
-
Abdullah KhanTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Halozyme TherapeuticsCompletedRisk Factors for or a Diagnosis of OsteoporosisUnited States
-
Baxter Healthcare CorporationHalozyme TherapeuticsTerminated
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)Denmark, United Kingdom, Czechia, France, Greece, Hungary, Slovakia, Sweden
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Spain, Netherlands, Sweden, Denmark, France
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.CompletedChronic Inflammatory Demyelinating PolyradiculoneuropathyUnited States, Israel, Canada, Spain, Czechia, Croatia, Poland, Italy, Serbia, Germany, Argentina, Mexico, Turkey, United Kingdom, Brazil, France, Greece, Slovakia, Colombia, Denmark, Norway, Sweden
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
TakedaTakeda Development Center Americas, Inc.RecruitingPrimary Immunodeficiency Diseases (PID)United States
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerSpain, Argentina, China, France, Turkey, Brazil, Korea, Republic of, Mexico, Chile, Guatemala, Peru, Thailand, Costa Rica, United Kingdom, New Zealand, Hungary, Latvia, Russian Federation, South Africa, Ukraine, Italy, Greece, Poland
-
Bristol-Myers SquibbCompleted
-
Halozyme TherapeuticsCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
Yale UniversityCompletedType 1 DiabetesUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedCannabis Use DisorderUnited States
-
Halozyme TherapeuticsCompleted
-
Bristol-Myers SquibbCompletedMalignant Solid TumorUnited States, France, Italy, Australia, Canada, Germany, Netherlands
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Australia, Canada, Japan
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Australia, Belgium, Italy, Poland, Spain, United Kingdom
-
Alexion Pharmaceuticals, Inc.Completed
-
Bristol-Myers SquibbWithdrawnMelanoma | Urothelial CarcinomaGermany, Spain
-
Bristol-Myers SquibbRecruitingClear Cell Renal Cell CarcinomaRussian Federation, New Zealand, United States, Finland, France, Ireland, Italy, Turkey, Poland, Argentina, Brazil, Chile, Czechia, Mexico, Portugal, Romania, Spain
-
Bristol-Myers SquibbActive, not recruitingNeoplasms by SiteUnited States, Mexico, Italy, Argentina, Brazil, Chile, France, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; Janssen Pharmaceuticals; Multiple Myeloma Research ConsortiumRecruitingMultiple MyelomaUnited States
-
Bristol-Myers SquibbRecruitingMelanomaUnited States, Canada, Switzerland, Italy, Spain, Australia, France, Belgium, Finland, Israel, Germany, Sweden, Argentina, Brazil, Colombia, Mexico, Norway, Chile, United Kingdom, Austria, Poland, Czechia
-
Genentech, Inc.TerminatedMultiple Myeloma | Non-Hodgkin Lymphoma | B-Cell LymphomaUnited States, Korea, Republic of
-
Halozyme TherapeuticsCompleted
-
Halozyme TherapeuticsCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Janssen, LPRecruitingMultiple MyelomaUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic AdenocarcinomaUnited States
-
University of AlbertaWithdrawnBurning Mouth Syndrome
-
Bristol-Myers SquibbTerminatedTumorItaly, United States, New Zealand